12,326 results match your criteria Extracorporeal Membrane Oxygenation


Y-style silicone stent for treatment of trachea massive hemoptysis supported by extracorporeal membrane oxygenation.

Chin Med J (Engl) 2019 Mar 19. Epub 2019 Mar 19.

Department of Respiratory and Critical Care Medicine, Zhengzhou University People's Hospital, Zhengzhou, Henan 450003, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CM9.0000000000000198DOI Listing

Safety and Putative Benefits of Tracheostomy Tube Placement in Patients on Extracorporeal Membrane Oxygenation: A Single-Center Experience.

J Intensive Care Med 2019 Mar 21:885066619837939. Epub 2019 Mar 21.

2 Critical Care Research Group, Adult Intensive Care Unit, The Prince Charles Hospital and University of Queensland, Brisbane, Queensland, Australia.

Purpose:: Patients supported with extracorporeal membrane oxygenation (ECMO) have been reported to have increased sedation requirements. Tracheostomies are performed in intensive care to facilitate longer term mechanical ventilation, reduce sedation, improve patient comfort, secretion clearance, and ability to speak and swallow. We aimed to investigate the safety of tracheostomy (TT) placement on ECMO, its impact on fluid intake, and the use of sedative, analgesic, and vasoactive drugs. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0885066619837939DOI Listing

The Recommendation and Use of Extracorporeal Membrane Oxygenation (ECMO) in Cases Reported to the California Poison Control System.

J Med Toxicol 2019 Mar 20. Epub 2019 Mar 20.

California Poison Control System (CPCS), Sacramento Division, 2450 48th St. ASB 1260, Sacramento, CA, 95817, USA.

Introduction: Antidotes are available to treat some specific poisonings; however, the mainstay of treatment for the poisoned patient remains supportive care. Extracorporeal membrane oxygenation (ECMO) is one of the most aggressive supportive measures available to manage poisoned patients.

Objective: To characterize the recommendation and use of ECMO in cases reported to the California Poison Control System (CPCS). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13181-019-00704-3DOI Listing

Venoarterial Extracorporeal Life Support Utilization in a Pediatric Trauma Patient Following a Severe Dog Mauling.

Pediatr Emerg Care 2019 Mar 19. Epub 2019 Mar 19.

From the University of North Carolina, Chapel Hill, NC.

According to the Centers for Disease Control and Prevention, approximately 4.5 million dog bites occur each year in the United States, and more than half of these cases affect children. An estimated 1 in 6 dog bites, representing more than 800,000 bite victims each year, requires some form of medical attention. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PEC.0000000000001753DOI Listing
March 2019
1 Read

Clinical Determination of Brain Death in Children Supported by Extracorporeal Membrane Oxygenation.

Neurocrit Care 2019 Mar 19. Epub 2019 Mar 19.

Division of Neurology, Children's National Medical Center, 111 Michigan Avenue NW, Washington, DC, 20010, USA.

Background/objective: Children supported by extracorporeal membrane oxygenation (ECMO) are at risk of catastrophic neurologic injury and brain death. Timely determination of brain death is important for minimizing psychological distress for families, resource allocation, and organ donation. Reports of successful determination of brain death in pediatric patients supported by ECMO are limited. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12028-019-00700-zDOI Listing

Patients With Refractory Out-of-Cardiac Arrest and Sustained Ventricular Fibrillation as Candidates for Extracorporeal Cardiopulmonary Resuscitation - Prospective Multi-Center Observational Study.

Circ J 2019 Mar 20. Epub 2019 Mar 20.

Department of Emergency Medicine, Teikyo University.

Background: We investigated whether patients with out-of-hospital cardiac arrest (OHCA) and sustained ventricular fibrillation/pulseless ventricular tachycardia (VF/pVT) or conversion to pulseless electrical activity/asystole (PEA/asystole) benefit more from extracorporeal cardiopulmonary resuscitation (ECPR). Methods and Results: We analyzed data from the Study of Advanced Life Support for Ventricular Fibrillation with Extracorporeal Circulation in Japan, which was a prospective, multicenter, observational study with 22 institutions in the ECPR group and 17 institutions in the conventional CPR (CCPR) group. Patients were divided into 4 groups by cardiac rhythm and CPR group. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1253/circj.CJ-18-1257DOI Listing

Negative-Pressure Wound Therapy for Managing Complicated Wounds at Extracorporeal Membrane Oxygenation Sites.

Adv Skin Wound Care 2019 Apr;32(4):183-189

In Seoul, South Korea, Yeseul Eom, MD, is a resident in the Department of Plastic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine; and Kyong-Je Woo, MD, PhD, is an assistant professor, Department of Plastic Surgery, Mokdong Hospital, College of Medicine, Ewha Womans University. Acknowledgments: This work was supported by the Ewha Womans University Research Grant of 2017.

Objective: To evaluate the effectiveness of negative-pressure wound therapy (NPWT) for management of wound complications at extracorporeal membrane oxygenation (ECMO) removal sites.

Methods: The authors retrospectively reviewed patients who underwent NPWT at ECMO removal sites followed by the development of wound complications including skin necrosis, lymphorrhea, and femoral vessel exposure. A nonadhesive bacteria-binding mesh was used as a wound contact layer of NPWT application. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.ASW.0000553596.11034.d7DOI Listing

Correlation Among Antifactor Xa, Activated Partial Thromboplastin Time, and Heparin Dose and Association with Pediatric Extracorporeal Membrane Oxygenation Complications.

ASAIO J 2019 Mar 13. Epub 2019 Mar 13.

Department of Pediatrics, Duke University Hospital, Durham, North Carolina.

Anticoagulation is essential during extracorporeal membrane oxygenation (ECMO) to prevent catastrophic circuit clotting. Several assays exist to monitor unfractionated heparin (UFH), the most commonly used anticoagulant during ECMO, but no single test or combination of tests has consistently been proven to be superior. This retrospective observational study examines the correlation among antifactor Xa level, activated partial thromboplastin time (aPTT), and UFH dose and the association between antifactor Xa level and aPTT with survival and hemorrhagic and thrombotic complications. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAT.0000000000000986DOI Listing

Successful Resuscitation Using Extracorporeal Membrane Oxygenation of 2 Patients With Severe Liver Rupture: A Case Report.

A A Pract 2019 Mar 14. Epub 2019 Mar 14.

Anesthesiology and Critical Care Medicine.

Extracorporeal membrane oxygenation is a rescue treatment for respiratory or cardiac failure. Its use is limited in patients predisposed to bleeding due to heparin administration. We present 2 patients with deranged coagulation after liver rupture successfully treated by extracorporeal membrane oxygenation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1213/XAA.0000000000000996DOI Listing

Status asthmaticus requiring extracorporeal membrane oxygenation associated with rhinovirus infection.

J Asthma 2019 Mar 18:1-4. Epub 2019 Mar 18.

a Division of Pulmonology , Nemours/Alfred I. duPont Hospital for Children , Wilmington , DE , USA.

Objective: Evolving research links human rhinovirus (HRV) with status asthmaticus (SA) as well as severe respiratory illness in patients with atopy and asthma. This case series reviews five episodes of HRV-associated SA that required extracorporeal membrane oxygenation (ECMO).

Methods: Charts of four patients, five total episodes of ECMO, with SA secondary to HRV were reviewed in this IRB-approved case series. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/02770903.2019.1565826DOI Listing

The Use of Extracorporeal Membrane Oxygenation in Life-Threatening Foreign Body Aspiration: Case Series, Review of Extracorporeal Life Support Organization Registry Data, and Systematic Literature Review.

J Emerg Med 2019 Mar 14. Epub 2019 Mar 14.

Division of Critical Care Medicine, Department of Pediatrics, University of Texas Southwestern Medical Center/Children's Health, Dallas, Texas.

Background: Foreign body aspiration (FBA) is a common cause of morbidity and mortality in children < 3 years of age. Guidelines recommend performing a bronchoscopy in any suspected or confirmed FBA. Extracorporeal membrane oxygenation (ECMO) can be used as a rescue mode of support in children with life-threatening FBA for stabilization before, during, and after removal. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jemermed.2019.01.036DOI Listing

Liver Transplant After Normothermic Regional Perfusion From Controlled Donors After Circulatory Death: The Norwegian Experience.

Transplant Proc 2019 Mar 28;51(2):475-478. Epub 2019 Jan 28.

Department of Transplantation Medicine, Division of Surgery, Inflammatory Medicine and Transplantation, Oslo University Hospital, Oslo, Norway; Faculty of Medicine, University of Oslo, Oslo, Norway.

Background: In order to meet the increasing demand for donor organs, the concept of donation after circulatory death (DCD) was reintroduced in Norway, first as a pilot study, followed by the use of DCD as institutional practice. We report the current Norwegian experience with liver transplant after DCD.

Methods: After acceptance from next of kin, life support was withdrawn from patients with devastating brain injury and cardiac arrest observed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2019.01.066DOI Listing

Molecular Alterations of Nucleocytoplasmic Transport in Patients on the Heart Transplantation Waiting List and Its Correlation With the Severity and Etiology of Heart Failure.

Transplant Proc 2019 Mar 12;51(2):369-371. Epub 2018 Dec 12.

Heart Failure and Transplant Unit, La Fe University and Polytechnic Hospital, Valencia, Spain.

Objectives: To evaluate whether the levels of some molecules implicated in nucleocytoplasmic transport in human cardiomyocytes are related to the severity of heart failure (HF) in patients on the heart transplantation (HT) waiting list, and to determine whether there is a differential pattern of molecular alteration between ischemic cardiomyopathy (ICM) and non-ischemic dilated cardiomyopathy (DCM).

Methods: Sixty-three blood samples collected before HT were analyzed to identify the levels of IMPORTIN5 (IMP5); IMPORTINalpha2; ATPaseCaTransp (ATPCa); NUCLEOPORIN153kDa (Nup153); NUCLEOPORIN160kDa (Nup160); RANGTPaseAP1 (RanGAP1) and EXPORTIN4 (EXP4). These data were then compared between patients with advanced HF with or without the need for ventricular support with extracorporeal membrane oxygenation (ECMO) as a bridge for HT, as well as between patients with non-ischemic DCM and patients with ICM. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2018.12.013DOI Listing

Challenges and safety of beta lactam desensitization during extracorporeal membrane oxygenation.

Ann Allergy Asthma Immunol 2019 Mar 13. Epub 2019 Mar 13.

Brigham and Women's Hospital, Boston, Massachusetts; Drug Hypersensitivity and Desensitization Center at Brigham and Women's Hospital.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10811206193018
Publisher Site
http://dx.doi.org/10.1016/j.anai.2019.03.005DOI Listing
March 2019
1 Read

Quality of Life and Lung Function in Survivors of Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome.

Anesthesiology 2019 Apr;130(4):572-580

From the Department of Anesthesia, Critical Care, and Emergency, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda - Ospedale Maggiore Policlinico, Milan (MI), Italy (G.G., V.S., D.T., R.R., A.P.) Department of Pathophysiology and Transplantation, University of Milan, Milan (MI), Italy (G.G., F.C., F.B., L.C.M., E.S., A.P.) Department of Preventive Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ca' Granda - Ospedale Maggiore Policlinico, Milan (MI), Italy (L.P.) Department of Anesthesiology, Emergency and Intensive Care Medicine, University of Göttingen, Göttingen, Germany (L.G.) Department of Health Sciences, University of Milan, Milan (MI), Italy (D.C.).

What We Already Know About This Topic: Extracorporeal membrane oxygenation is used in severe acute respiratory distress syndrome; whereas the long-term complications among survivors of acute respiratory distress syndrome treated without extracorporeal membrane oxygenation are well described, the status of extracorporeal membrane oxygenation survivors is poorly understood WHAT THIS ARTICLE TELLS US THAT IS NEW: In a single-center cohort of acute respiratory distress syndrome survivors, management with (vs. without) extracorporeal membrane oxygenation resulted in similar survival at 1 yr, pulmonary function, and computed tomography lung imaging, but less impairment in quality of life BACKGROUND:: Survivors of acute respiratory distress syndrome (ARDS) have long-term impairment of pulmonary function and health-related quality of life, but little is known of outcomes of ARDS survivors treated with extracorporeal membrane oxygenation. The aim of this study was to compare long-term outcomes of ARDS patients treated with or without extracorporeal membrane oxygenation. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00000542-201904000-0001
Publisher Site
http://dx.doi.org/10.1097/ALN.0000000000002624DOI Listing
April 2019
10 Reads

Effects of a physiotherapic program in patients on veno-venous extracorporeal membrane oxygenation. A 8 year single center experience.

Minerva Anestesiol 2019 Mar 12. Epub 2019 Mar 12.

Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.

Background: To date, there is no agreement on the timing to perform a physical session in patients on Veno-Venous Extracorporeal Membrane Oxygenation (VV-ECMO). We aimed to assess whether early physiotherapy (within the first week from ECMO start) could affect in-ICU mortality.

Methods: Our retrospective observational study included 101 adults supported on VV ECMO from 2009 to 2016, consecutively admitted at our ECMO referral Center in Florence (Italy). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.23736/S0375-9393.19.13287-7DOI Listing
March 2019
1 Read

Rezidivierende fulminante Myokarditis mit wiederholtem Einsatz der ECMO bei einem Kind.

Klin Padiatr 2019 Mar 14;231(2):80-86. Epub 2019 Mar 14.

Department of Perinatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

Recurrent myocarditis is rare with only few reports having been published for paediatric cases. Repeated use of extracorporeal membrane oxygenation is also uncommon. In this paper we will present a very rare case of a 7-year old girl with recurrent fulminant myocarditis with heart failure requiring cardiopulmonary resuscitation and mechanical circulatory support with extracorporeal membrane oxygenation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/a-0831-2593DOI Listing
March 2019
1 Read

Extracorporeal Membrane Oxygenation as a Salvage Therapy for Patients With Severe Primary Graft Dysfunction After Heart Transplant.

Clin Transplant 2019 Mar 14:e13538. Epub 2019 Mar 14.

Department of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, Florida.

Background: Severe primary graft dysfunction (PGD) is the leading cause of early death after heart transplant.

Aim: To examine the outcomes of heart transplant recipients who received venoarterial extracorporeal membrane oxygenation (VA-ECMO) for severe PGD.

Methods: We reviewed electronic health records of adult patients who underwent heart transplant from November 2005 through June 2015. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ctr.13538DOI Listing
March 2019
56 Reads
1.486 Impact Factor

Continuous monitoring of membrane lung carbon dioxide removal during ECMO: experimental testing of a new volumetric capnometer.

Perfusion 2019 Mar 14:267659119833233. Epub 2019 Mar 14.

1 Cardio-Thoracic Surgery Department, Heart+Vascular Centre, Maastricht University Medical Center, Maastricht, The Netherlands.

Background:: Extracorporeal membrane oxygenation constitutes a complex support modality, and accurate monitoring is required. An ideal monitoring system should promptly detect ECMO malfunctions and provide real-time information to optimize the patient-machine interactions. We tested a new volumetric capnometer which enables continuous monitoring of membrane lung carbon dioxide removal (V'COML), to help in estimating the oxygenator performance, in terms of CO removal and oxygenator dead space (VDsML). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0267659119833233DOI Listing
March 2019
2 Reads

Establishing an ECMO program in a developing country: challenges and lessons learned.

Perfusion 2019 Mar 14:267659119834489. Epub 2019 Mar 14.

3 Department of Surgery, American University of Beirut Medical Center, Beirut, Lebanon.

Aim:: The ECMO (extracorporeal membrane oxygenation) Program at the American University of Beirut Medical Center was established in November 2015 as the first program serving adult and pediatric population in a low-resource setting. The aim of the study is to describe the challenges faced during the establishment of the program and factors leading to its success.

Methods:: The program establishment is described. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0267659119834489DOI Listing
March 2019
1 Read

An artificial placenta type microfluidic blood oxygenator with double-sided gas transfer microchannels and its integration as a neonatal lung assist device.

Biomicrofluidics 2018 Jul 3;12(4):044101. Epub 2018 Jul 3.

Department of Pediatrics, McMaster University, Hamilton, Ontario L8S 4L7, Canada.

Preterm neonates suffering from respiratory distress syndrome require assistive support in the form of mechanical ventilation or extracorporeal membrane oxygenation, which may lead to long-term complications or even death. Here, we describe a high performance artificial placenta type microfluidic oxygenator, termed as a double-sided single oxygenator unit (dsSOU), which combines microwire stainless-steel mesh reinforced gas permeable membranes on both sides of a microchannel network, thereby significantly reducing the diffusional resistance to oxygen uptake as compared to the previous single-sided oxygenator designs. The new oxygenator is designed to be operated in a pumpless manner, perfused solely due to the arterio-venous pressure difference in a neonate and oxygenate blood through exposure directly to ambient atmosphere without any air or oxygen pumping. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1063/1.5034791DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404930PMC
July 2018
2 Reads

Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report.

BMC Pulm Med 2019 Mar 12;19(1):61. Epub 2019 Mar 12.

Department of Medicine, Tripler Army Medical Center, 1 Jarrett White Rd, Tripler AMC, Hawaii, 96859, USA.

Background: Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by accumulation of phospholipoproteinaceous material in the alveoli. The presentation is nonspecific but typically includes dyspnea; the spectrum of disease includes rapidly progressive hypoxic respiratory failure. Whole lung lavage (WLL) is the treatment of choice in symptomatic PAP, but transient worsening of oxygenation sometimes requires salvage modalities of support such as extracorporeal membrane oxygenation (ECMO). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12890-019-0822-xDOI Listing
March 2019
1 Read

Long-term outcomes after extracorporeal membrane oxygenation in patients with dialysis-requiring acute kidney injury: A cohort study.

PLoS One 2019 13;14(3):e0212352. Epub 2019 Mar 13.

Graduate Institute of Clinical Medical Science, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Background: Acute kidney injury (AKI) is a common complication of extracorporeal membrane oxygenation (ECMO) treatment. The aim of this study was to elucidate the long-term outcomes of adult patients with AKI who receive ECMO.

Materials And Methods: The study analyzed encrypted datasets from Taiwan's National Health Insurance Research Database. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0212352PLOS
March 2019
1 Read

Hemodynamic monitoring in the extracorporeal membrane oxygenation patient.

Curr Opin Crit Care 2019 Mar 5. Epub 2019 Mar 5.

Division of Pulmonary Diseases, Critical Care, and Occupational Medicine, University of Iowa, Iowa City, USA.

Purpose Of Review: Hemodynamic monitoring in ECMO patients requires familiarity with the underlying pathophysiology and circulatory mechanics of extracorporeal flow. This review discusses the various monitoring modalities relevant to the management of patients on venovenous ECMO (VV ECMO) and venoarterial (VA ECMO). We emphasize tools to judge the adequacy of perfusion, predict the response to fluid boluses, measure right ventricular function, assess left ventricular distention (for VA ECMO), and monitor the process of weaning from ECMO. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MCC.0000000000000602DOI Listing
March 2019
5 Reads

Prognostic Factors for Survival After Extracorporeal Membrane Oxygenation for Cardiogenic Shock.

ASAIO J 2019 Mar 6. Epub 2019 Mar 6.

From the National Heart Centre Singapore, 5 Hospital Drive, Singapore 169609, Singapore.

The aim of this study is to examine factors that can predict mortality in patients that have veno-arterial extracorporeal membrane oxygenation (VA-ECMO) instituted for cardiogenic shock. A single-center, retrospective study of 127 patients who underwent VA-ECMO for cardiogenic shock between January 2003 and December 2017 was conducted. Eighty-three (65%) patients survived to weaning or bridging therapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MAT.0000000000000984DOI Listing
March 2019
1 Read

Venoarterial Extracorporeal Membrane Oxygenation as Supportive Therapy After Cardiac Arrest After Amniotic Fluid Embolism: A Case Report.

A A Pract 2019 Mar 6. Epub 2019 Mar 6.

From the Departments of Anesthesiology and Surgical Intensive Care.

Amniotic fluid embolism is a rare but dreaded complication of pregnancy, with an incidence between 2 and 7/100,000 deliveries. We report an amniotic fluid embolism after urgent cesarean delivery diagnosed on a cardiac arrest, complicated by cardiogenic shock and acute respiratory distress syndrome. This report describes the indication, efficacy, and success of venoarterial extracorporeal membrane oxygenation in the early management of cardiac arrest, cardiac failure driven by amniotic fluid embolism, and acute respiratory distress syndrome. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1213/XAA.0000000000000995DOI Listing
March 2019
3 Reads

Quantitative assessment of peripheral limb perfusion using a modified distal arterial cannula in venoarterial ECMO settings.

Perfusion 2019 Mar 13:267659118816934. Epub 2019 Mar 13.

6 Department of Anaesthesia, University Hospital Regensburg, Regensburg, Germany.

In cases of severe cardiopulmonary deterioration, quick establishment of venoarterial extracorporeal membrane oxygenation (ECMO) represents a support modality. After successful arterial peripheral cannulation, a certain grade of peripheral limb malperfusion is a fairly common phenomenon. Detection of peripheral malperfusion is vital, since it can result in compartment syndrome or even loss of the affected limb. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0267659118816934DOI Listing

Clinical implications of the initial SAPS II in veno-arterial extracorporeal oxygenation.

J Thorac Dis 2019 Jan;11(1):68-83

Department of Thoracic and Cardiovascular Surgery, School of Medicine, Konkuk University, Konkuk University Chungju Hospital, Chungju-si, Chungbuk, Republic of Korea.

Background: Prediction of survival and weaning probability in VA ECMO (veno-arterial extracorporeal membrane oxygenation) patients could be of great benefit for real-time decision making on VA ECMO initiation in critical ill patients. We investigated whether the SAPS II score would be a real-time determinant for VA ECMO initiation and could be a predictor of survival and weaning probability in patients on VA ECMO.

Methods: Between January 1, 2010 and December 31, 2014, VA ECMO was carried out on 135 adult patients suffering from primary cardiogenic shock. Read More

View Article

Download full-text PDF

Source
http://jtd.amegroups.com/article/view/26062/19813
Publisher Site
http://dx.doi.org/10.21037/jtd.2018.12.20DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384379PMC
January 2019
2 Reads

ECMO for Adults with Severe Respiratory Failure.

Mo Med 2019 Jan-Feb;116(1):58-62

Jonathan Kozinn, MD and W. Cole Wrisinger, DO, are in the Department of Anesthesiology, Saint Luke's Hospital, University of Missouri - Kansas City, Kansas City, Missouri.

The technology to provide Extracorporeal Life Support (ELS) has existed for over four decades. Its use has increased markedly in the last decade, initially in response to severe Acute Respiratory Distress Syndrome (ARDS) in adults during the 2009 H1N1 influenza epidemic and continuing with the increasing acceptance of Extracorporeal Membrane Oxygenation (ECMO) for the treatment of severe respiratory failure in adults from other causes.1 We highlight the use of ECMO, particularly at our institution. Read More

View Article

Download full-text PDF

Source
March 2019
3 Reads

Transesophageal echocardiography identification of aortic dissection during cardiac arrest and cessation of ECMO initiation.

Am J Emerg Med 2019 Feb 27. Epub 2019 Feb 27.

University of Utah, Department of Anesthesiology, United States of America.

Cardiac arrest is a challenging clinical presentation that emergency medicine providers often encounter. Aortic dissection is an uncommon etiology in all-comers presenting in cardiac arrest. The use of bedside point of care echocardiography to aid in resuscitative efforts is expanding, particularly with the increasing use of transesophageal echocardiography (TEE) by emergency medicine providers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajem.2019.02.039DOI Listing
February 2019
1 Read

Triple bridge of mechanical circulatory support to heart transplantation listing: A case report.

SAGE Open Med Case Rep 2019 5;7:2050313X19834816. Epub 2019 Mar 5.

Department of Cardiothoracic Surgery, Mayo Clinic, Jacksonville, FL, USA.

A 60-year-old male patient presented to an outside hospital with severe cardiogenic shock. A triple bridge of mechanical circulatory support was utilized to transition him to heart transplantation listing. Initially, coronary artery disease was percutaneously treated and Impella 2. Read More

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/2050313X19834816
Publisher Site
http://dx.doi.org/10.1177/2050313X19834816DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404238PMC
March 2019
1 Read

Sepsis-induced heparin resistance during extracorporeal membrane oxygenation.

CMAJ 2019 Mar;191(10):E283-E285

Division of Cardiac Surgery (Hage, Kiaii), Department of Surgery; Division of Hematology (Louzada), Department of Medicine, Western University, London Health Sciences Centre, London, Ont.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1503/cmaj.181061DOI Listing

Cost-effectiveness of Antenatal Corticosteroid Therapy vs No Therapy in Women at Risk of Late Preterm Delivery: A Secondary Analysis of a Randomized Clinical Trial.

JAMA Pediatr 2019 Mar 11. Epub 2019 Mar 11.

Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston.

Importance: Administration of corticosteroids to women at high risk for delivery in the late preterm period (34-36 weeks' gestation) improves short-term neonatal outcomes. The cost implications of this intervention are not known.

Objective: To compare the cost-effectiveness of treatment with antenatal corticosteroids with no treatment for women at risk for late preterm delivery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamapediatrics.2019.0032DOI Listing

Preoperative balloon pulmonary angioplasty enabled noncardiac surgery of a patient with chronic thromboembolic pulmonary hypertension (CTEPH): A case report.

Medicine (Baltimore) 2019 Mar;98(10):e14807

Department of Anesthesiology, Faculty of Medicine, The University of Tokyo, Tokyo.

Rationale: Chronic thromboembolic pulmonary hypertension (CTEPH) is a disease with a poor prognosis, characterized by chronic thromboembolic obstruction of the pulmonary arteries and pulmonary hypertension. Balloon pulmonary angioplasty (BPA) is a newly emergent treatment for CTEPH, which may substitute pulmonary endarterectomy, the standard but more invasive treatment for CTEPH. Here, we report the case of a CTEPH patient who underwent 2 noncardiac surgeries without complications after preoperative intervention of BPA. Read More

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00005792-201903080-0006
Publisher Site
http://dx.doi.org/10.1097/MD.0000000000014807DOI Listing
March 2019
1 Read

Incidence and Risk Factors for Cannula-Related Venous Thrombosis After Venovenous Extracorporeal Membrane Oxygenation in Adult Patients With Acute Respiratory Failure.

Crit Care Med 2019 Apr;47(4):e332-e339

Department of Internal Medicine II, University Hospital Regensburg, Regensburg, Germany.

Objectives: Venovenous extracorporeal membrane oxygenation is indicated in patients with severe refractory acute respiratory failure. Venous thrombosis due to indwelling catheters is a frequent complication. The aim of this study was to analyze the incidence of cannula-related thrombosis and its risk factors after venovenous extracorporeal membrane oxygenation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000003650DOI Listing
April 2019
1 Read

Reply to 'Using intraaortic balloon pump to increase afterload during extracorporeal membrane oxygenation'.

Authors:
Maria Rodriguez

Perfusion 2019 Mar 11:267659119833535. Epub 2019 Mar 11.

Children's Hospital of Eastern Ontario, Ottawa, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0267659119833535DOI Listing

Weaning from veno-arterial extra-corporeal membrane oxygenation: which strategy to use?

Ann Cardiothorac Surg 2019 Jan;8(1):E1-E8

Department of Intensive Care Cnit, Hôpital Européen Georges Pompidou (HEGP) Assistance Publique-Hôpitaux de Paris (APHP) and Université Paris Descartes, Paris, France.

Refractory cardiogenic shock patients may be rescued by veno-arterial extracorporeal membrane oxygenation (VA ECMO). After a few days of mechanical assistance, the device can sometimes be successfully removed if the patient has partially or fully recovered from the condition that required the use of ECMO. The percentage of patients with refractory cardiogenic shock who are successfully weaned from ECMO varies from 31% to 76%. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.08.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379199PMC
January 2019

Preoperative and intraoperative extracorporeal membrane oxygenation adoption for long-term left ventricular assist device implantation.

Ann Cardiothorac Surg 2019 Jan;8(1):167-169

Department of Cardiovascular Surgery, University Hospital of Düsseldorf, Heinrich-Heine University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.10.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379203PMC
January 2019

Double, triple and quadruple cannulation for veno-arterial extracorporeal membrane oxygenation support: is there a limit?

Ann Cardiothorac Surg 2019 Jan;8(1):151-159

Department of Cardiovascular Surgery and Transplantation, St. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy.

Each cannulation strategy for venoarterial extracorporeal membrane oxygenation (VA ECMO) has distinct benefits and drawbacks. In this article, various cannulation strategies including their indications are discussed. The gold standard for cannulation involves peripheral, percutaneous double cannulation utilizing the patient's femoral vein and artery. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2019.01.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379187PMC
January 2019
1 Read

Extracorporeal membrane oxygenation for accidental deep hypothermia-current challenges and future perspectives.

Ann Cardiothorac Surg 2019 Jan;8(1):137-142

Department of Anesthesiology and Intensive Care Medicine, Medical University of Silesia, Katowice, Poland.

The incidence of accidental hypothermia (core temperature ≤35 °C) is difficult to estimate, as the affected population is heterogeneous. Both temperature and clinical presentation should be considered while determining severity, which is difficult in a prehospital setting. Extracorporeal rewarming is advocated for all Swiss Staging System class IV (hypothermic cardiac arrest) and class III (hypothermic cardiac instability) patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.10.12DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379186PMC
January 2019
1 Read

Traditional and non-traditional anticoagulation management during extracorporeal membrane oxygenation.

Ann Cardiothorac Surg 2019 Jan;8(1):129-136

Department of Anesthesia and Pain Medicine, Hospital for Sick Children, University of Toronto, Toronto, Canada.

Unfractionated heparin (UFH) is the anticoagulant of choice during extracorporeal membrane oxygenation (ECMO) support. Despite its favorable pharmacologic properties, management of heparin anticoagulation during ECMO remains a major challenge. To date, little is known about the optimal monitoring strategy or the heparin dose offering the best safety/efficacy profile. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.07.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379198PMC
January 2019

Cardiac catheterization and percutaneous intervention procedures on extracorporeal membrane oxygenation support.

Ann Cardiothorac Surg 2019 Jan;8(1):123-128

Annette C. and Harold C. Simmons Transplant Institute, Baylor Scott & White Research Institute, Dallas, TX, USA.

Extracorporeal membrane oxygenation (ECMO) is used to support critically ill patients when conventional therapies have failed. ECMO has been available for four decades and has gained use as a rescue therapy in severe refractory hypoxic disorders and in patients with refractory cardiogenic shock (RCS). Over recent years, several percutaneous cardiac interventions and implant devices have been developed that are now used frequently in conjunction with ECMO in order to maintain organ perfusion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.11.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379180PMC
January 2019
1 Read

Long-term survival and major outcomes in post-cardiotomy extracorporeal membrane oxygenation for adult patients in cardiogenic shock.

Ann Cardiothorac Surg 2019 Jan;8(1):116-122

Department of Cardio-Thoracic Surgery, Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands.

Extracorporeal membrane oxygenation (ECMO) in the veno-arterial (VA) configuration is an established method for the treatment of refractory cardiogenic shock. Such a condition characterizes the postoperative course of approximatively 1% of cardiac surgery patients. Although some studies have reported ECMO-related short-term results, little is known about the long-term outcomes of VA-ECMO therapy in the post-cardiotomy setting. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.04DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379181PMC
January 2019
1 Read

Extracorporeal membrane oxygenation support in pediatrics.

Ann Cardiothorac Surg 2019 Jan;8(1):109-115

Pediatric Cardiovascular Surgery, Pediatric Heart Center, Department of Surgery, University Children's Hospital Zurich, Zurich, Switzerland.

Extracorporeal membrane oxygenation (ECMO) is a general term that describes the short- or long-term support of the heart and/or lungs in neonates, children and adults. Due to favorable results and a steady decline in absolute contraindications, its use is increasing worldwide. Indications in children differ from those in adults. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.09.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379197PMC
January 2019
1 Read

Extracorporeal membrane oxygenation as treatment of graft failure after heart transplantation.

Ann Cardiothorac Surg 2019 Jan;8(1):99-108

Department of Cardiovascular Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.

Heart transplantation (HTx) is a valuable option in eligible patients with end-stage heart failure. The most significant complication in the immediate post-operative period is early graft failure (EGF), with a mean incidence of 20-25%. EGF is a major risk factor for death and accounts for 40-50% of early mortality after HTx. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.08DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379182PMC
January 2019
1 Read

The Extracorporeal Life Support Organization Registry: update and perspectives.

Ann Cardiothorac Surg 2019 Jan;8(1):93-98

Department of Pediatrics, C.S. Mott Children's Hospital, Ann Arbor, Michigan, USA.

From the birth of the Extracorporeal Life Support Organization (ELSO) Registry in 1989, collecting the most relevant information about extracorporeal life support (ECLS) for refractory cardiac or respiratory compromise, was created in order to provide useful information and benchmark for ECLS users. Throughout the years, the Registry has continuously developed, achieving in 2018 more than 100,000 patients included with almost 500 ELSO centers around the world. Based on the relevance and impact of database analysis, and due to the growing need for more advanced and high-quality clinical investigations, the ELSO Registry is under substantial re-engineering which will allow and provide the ELSO members and the scientific community an enhanced scientific tool to elucidate various aspects of the ECLS settings, including trends and disease-specific information, to perform benchmarking about our own results and outcomes as compared to regional or worldwide results, and to provide an invaluable source of data for clinical investigations. Read More

View Article

Download full-text PDF

Source
http://www.annalscts.com/article/view/16562/16878
Publisher Site
http://dx.doi.org/10.21037/acs.2018.11.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379190PMC
January 2019
2 Reads

Temporary mechanical circulatory support for refractory heart failure: the German Heart Center Berlin experience.

Ann Cardiothorac Surg 2019 Jan;8(1):76-83

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.

Background: Temporary mechanical circulatory support (MCS) offers a valuable option for treatment of refractory heart failure. We present our experience with selected MCS devices in cardiogenic shock of different etiologies.

Methods: We retrospectively studied patients who were treated in our institution between 01/2016 and 07/2018. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/acs.2018.12.01DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6379195PMC
January 2019
1 Read